Contrasting NeueHealth (NEUE) & Its Competitors

NeueHealth (NYSE:NEUE) is one of 14 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it contrast to its rivals? We will compare NeueHealth to related businesses based on the strength of its risk, institutional ownership, dividends, valuation, analyst recommendations, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for NeueHealth and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1116	2556	98	2.69

NeueHealth presently has a consensus price target of $8.00, indicating a potential upside of 36.99%. As a group, “Hospital & medical service plans” companies have a potential upside of 17.68%. Given NeueHealth’s higher probable upside, analysts plainly believe NeueHealth is more favorable than its rivals.

Institutional and Insider Ownership

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by company insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares NeueHealth and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	-0.12%	-1.59%	-0.02%

Valuation and Earnings

This table compares NeueHealth and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	9.44

NeueHealth’s rivals have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

NeueHealth has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s rivals have a beta of 0.95, suggesting that their average stock price is 5% less volatile than the S&P 500.

Summary

NeueHealth rivals beat NeueHealth on 9 of the 12 factors compared.

NeueHealth Company Profile

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.